Radiation-Fighting Drug

A hydroxylase inhibitor that prolongs the action of a gut-protective protein shows promise in mice as a treatment for radiation poisoning.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, NEPHRONA protein that protects the cells that line the gut may be able to prevent gastrointestinal damage following radiation, which can often be fatal, according to a study published this week (May 14) in Science Translational Medicine. A team led by Amato Giaccia of the Stanford University School of Medicine found that in mice a drug called dimethyloxallyl glycine (DMOG), which neutralizes enzymes that reduce levels of this protein, called hypoxia-inducible factor 2 (HIF2), protected against radiation-induced gut damage.

The work was funded by the National Institutes of Health as part of a plan to develop medical interventions for use after a “dirty bomb” is detonated. But Giaccia’s team next plans to develop a version of the drug that can be used to protect healthy cells in people undergoing radiation therapy. Current therapies concentrate radiation narrowly around the target, such as a tumor, but metastasized cancer cells can spread the disease to other parts of the body. With a drug like Giaccia’s to protect gut cells, cancer patients might be able to undergo full-body radiation therapy, perhaps halting the tumor’s spread.

“We’re thinking about using this to transform radiotherapy from a localized type of therapy to a systemic therapy,” Giaccia told Nature News. “The ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Rina Shaikh-Lesko

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide